APA (7th ed.) Citation

Pedersen, R. S., Thorlacius-Ussing, J., Raimondo, M. G., Langholm, L. L., Schett, G., Ramming, A., . . . Willumsen, N. (2024). Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis. Biomedicines, 12(3), 545. https://doi.org/10.3390/biomedicines12030545

Chicago Style (17th ed.) Citation

Pedersen, Rasmus S., Jeppe Thorlacius-Ussing, Maria G. Raimondo, Lasse L. Langholm, Georg Schett, Andreas Ramming, Morten Karsdal, and Nicholas Willumsen. "Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis." Biomedicines 12, no. 3 (2024): 545. https://doi.org/10.3390/biomedicines12030545.

MLA (9th ed.) Citation

Pedersen, Rasmus S., et al. "Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis." Biomedicines, vol. 12, no. 3, 2024, p. 545, https://doi.org/10.3390/biomedicines12030545.